ACADIA Pharmaceuticals
ACAD
#3702
Rank
NZ$4.69 B
Marketcap
$28.21
Share price
-2.73%
Change (1 day)
-27.00%
Change (1 year)

Operating Margin for ACADIA Pharmaceuticals (ACAD)

Operating Margin as of November 2024 (TTM): 5.13%

According to ACADIA Pharmaceuticals's latest financial reports and stock price the company's current Operating Margin is 5.13%. At the end of 2023 the company had an Operating Margin of -7.03%.

Operating Margin history for ACADIA Pharmaceuticals from 2003 to 2024

Operating Margin at the end of each year

Year Operating Margin Change
2023-7.03%-82.98%
2022-41.27%19.26%
2021-34.60%-45.6%
2020-63.60%-7.99%
2019-69.12%-36.58%
2018-108.99%-52.78%
2017-230.81%-85.19%
2016-1,558.20%-99.42%
2015-269,037.70%249.12%
2014-77,062.50%2225.2%
2013-3,314.24%680.04%
2012-424.88%-61.42%
2011-1,101.35%-3165.3%
201035.93%-105.06%
2009-710.55%-83.13%
2008-4,212.45%407.95%
2007-829.31%37.5%
2006-603.15%84.55%
2005-326.82%-42.34%
2004-566.79%204.37%
2003-186.22%-7.44%
2002-201.19%-51.09%
2001-411.39%

Operating Margin for similar companies or competitors

Company Operating Margin Operating Margin differencediff. Country
-17.83%-447.56%๐Ÿ‡บ๐Ÿ‡ธ USA
1.80%-64.91%๐Ÿ‡บ๐Ÿ‡ธ USA
24.84% 384.21%๐Ÿ‡บ๐Ÿ‡ธ USA
17.68% 244.64%๐Ÿ‡บ๐Ÿ‡ธ USA
-14.50%-382.65%๐Ÿ‡บ๐Ÿ‡ธ USA
-43.80%-953.85%๐Ÿ‡บ๐Ÿ‡ธ USA

What is a company's Operating Margin?

The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.